BioAtla (BCAB) Interest Coverage Ratio (2020 - 2026)
BioAtla (BCAB) posted quarterly Interest Coverage Ratio of 465.4 for Q1 2026, down 660.96% year-over-year from 82.97 in Q1 2025, and down 5371.12% quarter-over-quarter from 8.51 in Q3 2025.
BioAtla (BCAB) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
BioAtla's Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 465.4 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 660.96% year-over-year to 465.4; the TTM figure through Mar 2026 stood at 51.57 (down 5.21% YoY), while the FY2025 annual figure was 0.51, up 28.98% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 465.4, down from 8.51 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 0.01 in Q3 2022, with the low at 3248.8 in Q4 2024.
- The 5-year median for Interest Coverage Ratio is 27.21 (2024), against an average of 260.1.
- The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio soared 99.99% in 2022, then sank 432668.98% in 2023.
- BioAtla's Interest Coverage Ratio stood at 71.4 in 2022, then sank by 45.86% to 104.15 in 2023, then tumbled by 3019.47% to 3248.8 in 2024, then soared by 99.74% to 8.51 in 2025, then slumped by 5371.12% to 465.4 in 2026.
- Business Quant data shows BCAB's Interest Coverage Ratio at 465.4 in Q1 2026, 8.51 in Q3 2025, and 2.37 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | BioAtla | 5.28 Mn | 5.28 Mn | - | 20.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.03 |
| Mar 31, 2026 | -465.40 |
| Sep 30, 2025 | -8.51 |
| Jun 30, 2025 | -2.37 |
| Mar 31, 2025 | -61.16 |
| Dec 31, 2024 | -3,248.80 |
| Sep 30, 2024 | -8.87 |
| Jun 30, 2024 | -12.97 |
| Mar 31, 2024 | -0.05 |
| Dec 31, 2023 | -104.15 |
| Sep 30, 2023 | -41.44 |
| Jun 30, 2023 | -0.38 |
| Mar 31, 2023 | -71.08 |
| Dec 31, 2022 | -71.40 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | -0.47 |
| Mar 31, 2022 | -64.58 |
| Dec 31, 2021 | -17.13 |
| Sep 30, 2021 | -64.04 |
| Jun 30, 2021 | -2.00 |